Literature DB >> 1586090

The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

D A Drossman1, W G Thompson.   

Abstract

The irritable bowel syndrome is a common chronic disorder having a broad clinical spectrum of severity. Although only a small proportion of those afflicted seek medical help for their symptoms, a subset have severe and intractable symptoms. A positive diagnosis should be established from the history and physical examination; endoscopic and radiologic investigations should be minimized. We suggest that the physician also assess the severity of the illness based on its symptomatic and functional features and the patient's behavioral response. Classifying the disorder in this manner permits a graduated treatment approach that emphasizes education, reassurance, and dietary adjustment for mild symptoms. Moderate symptom severity requires, in addition, identification and modification of factors exacerbating symptoms, psychotherapeutic and behavioral techniques and, if a certain symptom type predominates, pharmacologic agents directed toward the presumed gastrointestinal motor dysfunction. For severe symptoms, physician-based behavior modification and psychopharmacologic agents are helpful. When the disorder is intractable, referral may be needed, for example, to a pain treatment center. In all cases, the skillful physician must ensure continued psychosocial support to enhance coping and continued focus on the palliative aspects of care rather than on cure.

Entities:  

Mesh:

Year:  1992        PMID: 1586090     DOI: 10.7326/0003-4819-116-12-1009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  47 in total

1.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

2.  Colonic motor function in humans is not affected by gender.

Authors:  E E Soffer; K Kongara; J P Achkar; J Gannon
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

3.  Irritable Bowel Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 4.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 5.  Irritable bowel syndrome. Diagnosis in the managed care era.

Authors:  G F Longstreth
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

6.  Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study.

Authors:  M A McNally; G R Locke; A R Zinsmeister; C D Schleck; J Peterson; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

Review 7.  Non-invasive investigation of inflammatory bowel disease.

Authors:  J A Tibble; I Bjarnason
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

8.  The status and future of acupuncture clinical research.

Authors:  Jongbae Park; Klaus Linde; Eric Manheimer; Albrecht Molsberger; Karen Sherman; Caroline Smith; Joseph Sung; Andrew Vickers; Rosa Schnyer
Journal:  J Altern Complement Med       Date:  2008-09       Impact factor: 2.579

9.  Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study.

Authors:  C T Lee; T Y Chuang; C L Lu; C Y Chen; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

10.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.